Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Is LENZ Therapeutics (NASDAQ:LENZ) Trading Below Cash at USD 3.41 After a 5.68% Drop and a Fresh Low on VIZZ Launch Doubts?

No company release dated October 13 was found in company filings and wire releases reviewed, so the most relevant recent updates are summarized here. LENZ Therapeutics sells VIZZ, the first aceclidine eye drop for presbyopia, and reported second-quarter 2026 revenue of USD 5.5 million, …

Vinay Lochav | 13 October 2026

Can Intellia Therapeutics (NASDAQ:NTLA) Hold USD 11.95 After a 4.97% Drop on 3.4 Times Normal Volume With an HAE BLA in Review?

No company release dated October 13 was found in company filings and wire releases reviewed, so the most relevant recent updates are summarized here. Intellia Therapeutics, a CRISPR gene editing company, fell 4.97% to USD 11.95 on volume of 13.954 million shares, about 3.4 …

Vinay Lochav | 13 October 2026

Can Novavax (NASDAQ:NVAX) Hold USD 12.68 Near Its 52-Week High With Raised Revenue Guidance and USD 350 Million of Sanofi Milestones?

No company release dated October 13 was found in company filings and wire releases reviewed, so the most relevant recent updates are summarized here. Novavax reported second-quarter 2026 total revenue of USD 57 million, down 76% from USD 239 million a year earlier, when …

Vinay Lochav | 13 October 2026

Can Recursion Pharmaceuticals (NASDAQ:RXRX) Hold USD 3.85 After a 3.99% Drop With About USD 546 Million of Cash and 2028 Runway?

No company release dated October 13 was found in company filings and wire releases reviewed, so the most relevant recent updates are summarized here. Recursion, an AI-driven drug discovery company, fell 3.99% to USD 3.85 on volume of 30.79 million shares, 1.5 times its …

Vinay Lochav | 13 October 2026

Why Did Scinai Immunotherapeutics (NASDAQ:SCNI) Jump 15.64% After a USD 5.1 Million CDMO Deal Tripled Its Committed Orders?

Scinai Immunotherapeutics, a Jerusalem biopharma that also runs a contract development and manufacturing business, announced on October 13 that Scinai Biopharma Services signed a definitive agreement worth about USD 5.1 million in committed base fees for chemistry, manufacturing and controls development and clinical manufacturing …

Vinay Lochav | 13 October 2026

Why Is Tenon Medical (NASDAQ:TNON) Down 2.01% on Light Volume at a 94% Discount to Its 52-Week High?

No company release dated October 13 was found in company filings and wire releases reviewed, so the most relevant recent updates are summarized here. Tenon Medical is a medical device company whose Catamaran system treats sacroiliac joint dysfunction, and it fell 2.01% to USD …

Vinay Lochav | 13 October 2026

Why Did Bristol Myers (NYSE:BMY) Fall 1.65% After Trial Wins?

Bristol Myers Squibb (NYSE:BMY) fell USD 0.95 to USD 56.63 on 12.927 million shares, about 1.2 times its 3-month average of 11.217 million. The news was positive but mixed: the Phase 3 trial of admilparant in idiopathic pulmonary fibrosis met its primary endpoint at …

Vinay Lochav | 13 October 2026

Why Did China Pharma Holdings (NYSEAMERICAN:CPHI) Fall 13.47% After a USD 5 Million Offering Following a 79% Spike in July?

No company release dated October 13 was found in company filings and wire releases reviewed, so the most relevant recent updates are summarized here. China Pharma Holdings is a Haikou-based specialty pharmaceutical company with eight GMP-certified product lines, listed on NYSE American. NYSE American …

Vinay Lochav | 13 October 2026

Why Is Hyperfine (NASDAQ:HYPR) Down 3.83% After Preliminary Q3 Revenue Up 53% and Cash Burn Down 29%?

Hyperfine, maker of the Swoop portable MRI brain imaging system, issued a preliminary third-quarter 2026 update showing revenue of about USD 6.0 million, up roughly 53% sequentially and about 55% year over year, and net cash burn of about USD 5.6 million, down about …

Vinay Lochav | 13 October 2026

Is DataMeds AI (NASDAQ:MEDS) Stabilizing After a 0.65% Dip, a 1-for-50 Reverse Split and Lock-Ups on 49% of Shares?

No company release dated October 13 was found in company filings and wire releases reviewed, so the most relevant recent updates are summarized here. DataMeds AI, a Tampa-based health IT company that changed its name from Wellgistics Health in July and began trading as …

Vinay Lochav | 13 October 2026
Support

Hi! How can we help you today?

Loading…